The PRECISE-DAPT Score was developed to predict the risk of bleeding in patients treated with dual antiplatelet therapy (i.e. aspirin plus a P2Y12 inhibitor). The Score was developed from a collaborative dataset including data from 8 randomized clinical trials. Bleeding events were defined according to the Thrombosis in myocardial infarction (TIMI) bleeding definition. 

The PRECISE-DAPT Score and all related materials are for exclusive use of health care professionals and is intended as a supportive risk assessment tool which should never replace clinical judgment, physician–patient relationship or medical advice. 

Treatment risks and benefits should always be considered in the context of a comprehensive professional clinical assessment, taking into account all available data and treatment options. Physicians and other healthcare providers should always exercise their own clinical judgment for any given situation.

Terms of service for email reporting

Accepting the terms of service you accept to provide the PRECISE-DAPT score website with your email address to deliver the calculated score report. No data regarding patient’s identity will be entered, managed or stored through this website to grant full patients privacy. The score report will be used by the medical professional according to his/her own judgment and in accordance with the local privacy policy. The medical professional will commit to not include or divulgate patients' identification data through this website, in respect of patients' anonimity. The email address inserted for the report delivery may be used for the communication of scientific contents including future PRECISE-DAPT score related projects or publications, software updates and other relevant promotional messages in the medical field. All information included by the user in this website will be stored for future analysis and data quality check, in order to continuously improve the calculator experience.